Corporate | Regen Lab

ESSM-REGENLAB Webinar Series #2

par Marc Antoine Aimé | Juin 30, 2025 | Corporate

The replay of the ESSM Webinar Series 2024 session, hosted in collaboration with RegenLab, is now available to watch. Female regenerative therapies. State of the art. Watch replay  Moderators Giovanni CoronaMD PhDEndocrinology Unit Prof Dr Daniar...

RegenLab USA Opens New R&D and Manufacturing Facility in Jersey City

par Marc Antoine Aimé | Juin 17, 2025 | Corporate

RegenLab USA Opens New R&D and Manufacturing Facility in Jersey City Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to...

Nordic Partnership

par Marc Antoine Aimé | Fév 12, 2025 | Corporate

SE | NO | DK : A New Era in Regenerative Medicine Distribution We are thrilled to announce the beginning of a new era in the distribution of Regen Lab products across Sweden, Norway, and Denmark. This exciting development is made possible through our esteemed...

BeNeLux Partnership

par Marc Antoine Aimé | Fév 10, 2025 | Corporate

Regenerative Medicine Expansion in the BeNeLux Region We are pleased to announce an exciting development for Regen Lab in the BeNeLux region. To enhance our presence and ensure optimal service, we have established a new distribution network in collaboration with...



RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.



RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.



RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.



RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).



Hyaluronic Acid

Coming Soon



Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.



Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.



Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.